Table of Content

1 Markets
1.1 Product Definition
1.1.1 Inclusion and Exclusion Criteria
1.2 Market Scope
1.2.1 Scope of the Study
1.2.2 Key Questions Answered in the Report
1.3 Research Methodology
1.3.1 Global cell-free RNA isolation and extraction kits market: Research Methodology
1.3.2 Data Sources
1.3.2.1 Primary Data Sources
1.3.2.2 Secondary Data Sources
1.3.3 Market Estimation Model
1.3.4 Criteria for Company Profiling
1.4 Market Overview
1.4.1 Introduction: Cell-Free RNA
1.4.2 Emergence of Cell-Free RNA
1.4.3 Spin Column-Based Technology
1.4.4 Magnetic Bead-Based Technology
1.4.5 Market Size and Growth Potential, $Million, 2021-2032
1.5 Patent Landscape
1.5.1 Patent Filing Trend
1.5.2 Patent Analysis (by Year)
1.5.3 Patent Analysis (by Country)
1.5.4 Patent Analysis (by Region)

2 Industry Analysis
2.1 Overview
2.2 Regulatory Framework in the U.S.
2.2.1 FDA Regulations
2.3 Regulatory Framework in the European Union (EU)
2.4 Regulatory Framework in Asia-Pacific
2.4.1 China
2.4.2 Japan

3 Market Dynamics
3.1 Market Dynamics
3.1.1 Overview
3.2 Impact Analysis
3.3 Market Drivers
3.3.1 Increasing Incidence of Cancer
3.3.2 Increasing Number of Cases with Prenatal Complications
3.3.3 Advancement in the RNA Sequencing Technology
3.4 Market Restraints
3.4.1 Lack of Skilled Professionals and Awareness Related to Cell-Free RNA Methods
3.4.2 Ethical, Legal, and Social Issues Associated with Prenatal Screening
3.5 Market Opportunities
3.5.1 Growth in Emerging Nations
3.5.2 Rising Funding Activities for Cell-Free RNA Biomarkers

4 Competitive Landscape
4.1 Overview
4.1.1 Corporate Strategies
4.1.1.1 Synergistic Activities
4.1.2 Business Strategies
4.1.2.1 Product Launches
4.2 Market Share Analysis
4.3 Growth-Share Analysis (by Company)

5 Application, $Million, 2021-2032
5.1 Overview
5.2 Oncology
5.3 Prenatal Screening (Preeclampsia)
5.4 Metabolic Disorders

6 End Users, $Million, 2021-2032
6.1 Overview
6.2 Academic Research Institutions and Laboratories
6.3 Hospitals
6.4 Pharmaceutical and Biotechnology Companies
6.5 Diagnostic Laboratories

7 Region, $Million, 2021-2032
7.1 Overview
7.2 North America
7.3 Europe
7.4 Asia-Pacific (APAC)
7.5 Latin America
7.6 Rest-of-the-World

8 Company Profiles
8.1 Overview
8.2 Aline Biosciences
8.2.1 Company Overview
8.2.2 Role of Aline Biosciences in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.2.3 Key Competitors of the Company
8.2.4 Analyst Perspective
8.3 Apostle Sciences
8.3.1 Company Overview
8.3.2 Role of Apostle Sciences in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.3.3 Key Competitors of the Company
8.3.4 Analyst Perspective
8.4 Danagen-Bioted, S.L.
8.4.1 Company Overview
8.4.2 Role of Danagen-Bioted, S.L. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.4.3 Key Competitors of the Company
8.4.4 Analyst Perspective
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Role of F. Hoffmann-La Roche Ltd. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.5.3 Key Customers of the Company
8.5.4 Key Competitors of the Company
8.5.5 Financials
8.5.6 Analyst Perspective
8.6 JBS Science Inc.
8.6.1 Company Overview
8.6.2 Role of JBS Science Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.6.3 Key Competitors of the Company
8.6.4 Corporate Strategies
8.6.4.1 Synergistic Activities
8.6.4.1.1 Agreement
8.6.5 Analyst Perspective
8.7 Norgen Biotek Corp.
8.7.1 Company Overview
8.7.2 Role of Norgen Biotek Corp. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.7.3 Key Customers of the Company
8.7.4 Key Competitors of the Company
8.7.5 Business Strategies
8.7.5.1 Product Launch
8.7.6 Analyst Perspective
8.8 PerkinElmer, Inc.
8.8.1 Company Overview
8.8.2 Role of PerkinElmer, Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.8.3 Key Customers of the Company
8.8.4 Key Competitors of the Company
8.8.5 Financials
8.8.6 Key Insights about the Financial Health of the Company
8.8.7 Analyst Perspective
8.9 Promega Corporation
8.9.1 Company Overview
8.9.2 Role of Promega Corporation in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.9.3 Key Competitors of the Company
8.9.4 Business Strategies
8.9.4.1 Product Launch
8.9.5 Analyst Perspective
8.1 QIAGEN N.V.
8.10.1 Company Overview
8.10.2 Role of QIAGEN N.V. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.10.3 Key Customers of the Company
8.10.4 Key Competitors of the Company
8.10.5 Financials
8.10.6 Key Insights About the Financial Health of the Company
8.10.7 Business Strategies
8.10.7.1 Product Launch
8.10.8 Analyst Perspective
8.11 Streck, Inc.
8.11.1 Company Overview
8.11.2 Role of Streck, Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.11.3 Key Customers of the Company
8.11.4 Key Competitors of the Company
8.11.5 Business Strategies
8.11.5.1 Product Launch
8.11.6 Analyst Perspective
8.12 Thermo Fisher Scientific Inc.
8.12.1 Company Overview
8.12.2 Role of Thermo Fisher Scientific Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.12.3 Key Customers of the Company
8.12.4 Key Competitors of the Company
8.12.5 Financials
8.12.6 Key Insights About the Financial Health of the Company
8.12.7 Analyst Perspective
8.13 Takara Bio Inc.
8.13.1 Company Overview
8.13.2 Role of Takara Bio Inc. in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.13.3 Key Customers of the Company
8.13.4 Key Competitors of the Company
8.13.5 Financials
8.13.6 Analyst Perspective
8.14 Zymo Research Corporation
8.14.1 Company Overview
8.14.2 Role of Zymo Research Corporation in the Global Cell-Free RNA Isolation and Extraction Kits Market
8.14.3 Key Competitors of the Company
8.14.4 Analyst Perspective

List of Figures
Figure 1: Global Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021 and 2032
Figure 2: Global Cell-Free RNA Isolation and Extraction Kits Market Segmentation
Figure 3: Global Cell-Free RNA Isolation and Extraction Kits Market (by Application), $Million, 2021-2032
Figure 4: Global Cell-Free RNA Isolation and Extraction Kits Market (by End User), $Million, 2021-2032
Figure 5: Global Cell-Free RNA Isolation and Extraction Kits Market (by Region)
Figure 6: Global Cell-Free RNA Isolation and Extraction Kits Market Segmentation
Figure 7: Global Cell-Free RNA Isolation and Extraction Kits Market: Research Methodology
Figure 8: Primary Research Methodology
Figure 9: Bottom-Up Approach (Segment-Wise Analysis)
Figure 10: Top-Down Approach (Segment-Wise Analysis)
Figure 11: Global Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032
Figure 12: Global Cell-Free RNA Isolation and Extraction Kits Market, Patent Analysis (by Year), January 2019-June 2022
Figure 13: Global Cell-Free RNA Isolation and Extraction Kits Market, Patent Analysis (by Country), January 2019-June 2022
Figure 14: Global Cell-Free RNA Isolation and Extraction Kits Market, Patent Analysis (by Region), January 2019-June 2022
Figure 15: FDA Classification for Medical Devices
Figure 16: Overview of Regulatory Process for Medical Devices in the U.S.
Figure 17: Overview of Regulatory Process in the European Union (EU)
Figure 18: Overview of Regulatory Process for Medical Devices in China
Figure 19: Global Cell-Free RNA Isolation and Extraction Kits Market Dynamics
Figure 20: Global Cancer Incidence, 2017-2021
Figure 21: Maternal Mortality Rate, Region-Wise, 2020
Figure 22: Maternal Mortality Rate in the U.S.
Figure 23: Ethical, Legal, and Social Issues
Figure 24: Funding Scenario in the Global Cell-Free RNA Isolation and Extraction Kits Market, $Million, January 2019-February 2022
Figure 25: Share of Key Developments, January 2019-February 2022
Figure 26: Share of Product Launches and Upgrades (by Company), January 2019-February 2022
Figure 27: Market Share Analysis of Global Cell-Free RNA Isolation and Extraction Kits Market (by Company), 2020 and 2021
Figure 28: Growth-Share Analysis for Global Cell-Free RNA Isolation and Extraction Kits Market (by Company), 2021
Figure 29: Global Cell-Free RNA Isolation and Extraction Kits Market (by Application), $Million, 2021-2032
Figure 30: Global Cell-Free RNA Isolation and Extraction Kits Market (Oncology), $Million, 2021-2032
Figure 31: Global Cell-Free RNA Isolation and Extraction Kits Market (Prenatal Screening), $Million, 2021-2032
Figure 32: Global Cell-Free RNA Isolation and Extraction Kits Market (Metabolic Disorders), $Million, 2021-2032
Figure 33: Global Cell-Free RNA Isolation and Extraction Kits Market (by End User), $Million, 2021-2032
Figure 34: Global Cell-Free RNA Isolation and Extraction Kits Market (Academic Research Institutions and Laboratories), 2021-2032
Figure 35: Global Cell-Free RNA Isolation and Extraction Kits Market (Hospitals), 2021-2032
Figure 36: Global Cell-Free RNA Isolation and Extraction Kits Market (Pharmaceutical and Biotechnology Companies), $Million, 2021-2032
Figure 37: Global Cell-Free RNA Isolation and Extraction Kits Market (Diagnostic Laboratories), $Million, 2021-2032
Figure 38: Global Cell-Free RNA Isolation and Extraction Kits Market (by Region)
Figure 39: Global Cell-Free RNA Isolation and Extraction Kits Market (by Region), 2021 and 2032
Figure 40: North America Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032
Figure 41: Europe Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032
Figure 42: Asia-Pacific Cell-Free RNA Isolation and Extraction kits Market, $Million, 2021-2032
Figure 43: Latin America Cell-Free RNA Isolation and Extraction Kits Market, $Million, 2021-2032
Figure 44: Rest-of-the-World Cell-Free RNA Isolation and Extraction kits Market, $Million, 2021-2032
Figure 45: Total Number of Companies Profiled
Figure 46: Aline Biosciences: Product Portfolio
Figure 47: Apostle Sciences: Product Portfolio
Figure 48: Danagen-Bioted, S.L.: Product Portfolio
Figure 49: F. Hoffmann-La Roche Ltd.: Product Portfolio
Figure 50: F. Hoffmann-La Roche Ltd.: Overall Financials, 2019-2021
Figure 51: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), $Million, 2019-2021
Figure 52: F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2019-2021
Figure 53: F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2019-2021
Figure 54: JBS Science Inc.: Product Portfolio
Figure 55: Norgen Biotek Corp.: Product Portfolio
Figure 56: PerkinElmer, Inc.: Product Portfolio
Figure 57: PerkinElmer, Inc.: Overall Financials, $Million, 2019-2021
Figure 58: PerkinElmer, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 59: PerkinElmer, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 60: PerkinElmer, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 61: Promega Corporation: Product Portfolio
Figure 62: QIAGEN N.V.: Product Portfolio
Figure 63: QIAGEN N.V.: Overall Financials, $Million, 2019-2021
Figure 64: QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021
Figure 65: QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021
Figure 66: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021
Figure 67: Streck, Inc.: Product Portfolio
Figure 68: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 69: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021
Figure 70: Company Name: Revenue (by Segment), $Million, 2019-2021
Figure 71: Company Name: Revenue (by Region), $Million, 2019-2021
Figure 72: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021
Figure 73: Takara Bio Inc.: Product Portfolio
Figure 74: Takara Bio Inc.: Overall Financials, 2019-2022
Figure 75: Takara Bio Inc.: Revenue (by Segment), $Million, 2019-2022
Figure 76: Takara Bio Inc.: Revenue (by Region), $Million, 2019-2022
Figure 77: Takara Bio Inc.: R&D Expenditure, $Million, 2019-2022
Figure 78: Zymo Research Corporation: Product Portfolio

List of Tables
Table 1: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Global Cell-Free RNA Isolation and Extraction Kits Market
Table 2: Different Types of Cell-Free RNA in Serum/Plasma
Table 3: Examples of Spin-Column Technology-Based Cell-Free RNA Isolation and Extraction Kits
Table 4: Examples of Magnetic-Bead Technology Based Cell-Free RNA Isolation and Extraction Kits
Table 5: Likert Scale
Table 6: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Global Cell-Free RNA Isolation and Extraction Kits Market